2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea

Committee of Clinical Practice Guidelines, Korean Diabetes Association

    Research output: Contribution to journalArticlepeer-review

    152 Citations (Scopus)


    The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.

    Original languageEnglish
    Pages (from-to)398-406
    Number of pages9
    JournalDiabetes and Metabolism Journal
    Issue number4
    Publication statusPublished - 2019 Aug 1


    • Diabetes mellitus, type 2
    • Diagnosis
    • Practice guideline
    • Therapeutics

    ASJC Scopus subject areas

    • Endocrinology, Diabetes and Metabolism


    Dive into the research topics of '2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea'. Together they form a unique fingerprint.

    Cite this